Clinical Trial

Intent of Surgery for IPMN

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 14, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
This multicenter retrospective observational cohort study seeks to: 1. Classify surgical intent in patients with resected Intraductal Papillary Mucinous Neoplasms (IPMN) and quantify the proportion of IPMN-associated cancers diagnosed as overt pancreatic cancer with incidental IPMN association on pathology. 2. Compare clinicopathologic features and outcomes between surveillance-detected and incidentally detected IPMN-derived pancreatic cancers. 3. Revise and redefine risk features limited to patients undergoing surgery for IPMN-related indications, identifying optimal predictors of malignant IPMN (high-grade dysplasia or invasive cancer).
Trial Details
NCT Number NCT07216521
Lead Sponsor NYU Langone Health
Conditions Intraductal Papillary Mucinous Neoplasm
Enrollment 2,000 participants
Start Date 2025-09-15
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-10-14